60 Degrees Pharma Expands ARAKODA Access via Runway Health Partnership
Event summary
- 60 Degrees Pharmaceuticals partners with Runway Health to offer ARAKODA® through a travel-focused telehealth platform.
- ARAKODA® is the only FDA-approved, once-weekly malaria prevention option for international travelers.
- Partnership commences April 2, 2026, adding a new distribution channel for ARAKODA®.
- Runway Health provides physician-led online consultations and home delivery of medication.
- ARAKODA® requires a 3-day loading phase before travel, followed by weekly dosing during and after travel.
The big picture
This partnership aligns with the growing trend of telehealth solutions in the pharmaceutical industry, particularly for travel-related healthcare needs. By leveraging Runway Health's platform, 60 Degrees Pharma aims to streamline access to ARAKODA®, potentially increasing its reach among travelers to malaria-endemic regions. The strategic move could enhance the company's competitive position in the malaria prevention market.
What we're watching
- Market Penetration
- How the partnership will affect ARAKODA®'s market share among international travelers.
- Regulatory Compliance
- Whether 60 Degrees Pharma can maintain compliance with FDA regulations while expanding access.
- Execution Risk
- The pace at which Runway Health can integrate ARAKODA® into its platform and scale operations.
Related topics